Growth Metrics

BioNexus Gene Lab (BGLC) Current Deferred Tax Assets (2021)

BioNexus Gene Lab's Current Deferred Tax Assets history spans 1 years, with the latest figure at $67606.0 for Q4 2021.

  • Quarterly results put Current Deferred Tax Assets at $67606.0 for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $67606.0 (changed N/A YoY), and the annual figure for FY2021 was $67606.0, changed.
  • Current Deferred Tax Assets for Q4 2021 was $67606.0 at BioNexus Gene Lab.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $67606.0 in Q4 2021 to a low of $67606.0 in Q4 2021.